KLOW 80mg

KLOW 80mg is a multi-peptide research formulation combining four chemically distinct peptide materials in a single research vial.

The commonly referenced KLOW 80mg formulation contains:

• GHK-Cu — 50mg
• BPC-157 — 10mg
• TB-500 — 10mg
• KPV — 10mg
• Total nominal content — 80mg

The components remain separate molecular entities within the formulation; KLOW is therefore a co-formulated peptide blend rather than a single peptide with one molecular structure or amino-acid sequence.

Research Components

GHK-Cu is a copper-binding tripeptide investigated in laboratory models involving peptide–metal interactions, extracellular-matrix biology, and cellular signaling.

BPC-157 is a synthetic peptide used experimentally in biochemical, cellular, and molecular research models.

TB-500 refers to the N-terminal acetylated thymosin beta-4 fragment LKKTETQ and is investigated in peptide-characterization and cellular-signaling research.

KPV is the tripeptide Lys-Pro-Val, studied experimentally in molecular and biochemical pathway research.

Because the exact four-component KLOW formulation does not have an established clinical evidence base, findings associated with individual ingredients should not be treated as evidence of safety or effectiveness for the combined blend in humans.

Laboratory Research Areas

KLOW may be relevant to controlled research involving:

• Multi-peptide interaction studies
• Peptide identity and characterization
• Cellular signaling pathways
• Extracellular-matrix research
• Peptide stability analysis
• Molecular interaction studies
• In-vitro experimental systems
• Structure–activity research
• Analytical method development
• Comparative peptide investigations

Product Information

• Product: KLOW
• Total Strength: 80mg
• GHK-Cu: 50mg
• BPC-157: 10mg
• TB-500: 10mg
• KPV: 10mg
• Classification: Four-component research peptide blend
• Primary Research Area: Cellular and peptide research
• Supplier: Peptides R US

Regulatory / Research Use Notice

This material is offered solely for legitimate laboratory, analytical, and scientific research purposes.

It is not intended for human or veterinary consumption or administration and is not intended to diagnose, treat, cure, mitigate, or prevent any disease or medical condition.

No dosage, injection, reconstitution-for-human-use, therapeutic, recovery, wound-healing, or clinical instructions are provided or implied.

FDA currently identifies specific safety-information limitations for BPC-157, KPV, TB-500, and injectable GHK-Cu. Among other concerns, FDA notes limited or absent human safety data and potential issues involving immunogenicity, aggregation, peptide-related impurities, or API characterization depending on the substance.